
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children’s Oncology Group
Lisa Eidenschink Brodersen, Todd A. Alonzo, Andrew J. Menssen, et al.
Leukemia (2016) Vol. 30, Iss. 10, pp. 2077-2080
Open Access | Times Cited: 69
Lisa Eidenschink Brodersen, Todd A. Alonzo, Andrew J. Menssen, et al.
Leukemia (2016) Vol. 30, Iss. 10, pp. 2077-2080
Open Access | Times Cited: 69
Showing 1-25 of 69 citing articles:
How I treat pediatric acute myeloid leukemia
Jeffrey E. Rubnitz, Gertjan J.L. Kaspers
Blood (2021) Vol. 138, Iss. 12, pp. 1009-1018
Open Access | Times Cited: 76
Jeffrey E. Rubnitz, Gertjan J.L. Kaspers
Blood (2021) Vol. 138, Iss. 12, pp. 1009-1018
Open Access | Times Cited: 76
Comprehensive molecular and clinical characterization of <i>NUP98</i> fusions in pediatric acute myeloid leukemia
Eline J.M. Bertrums, Jenny L. Smith, Lauren Harmon, et al.
Haematologica (2023) Vol. 108, Iss. 8, pp. 2044-2058
Open Access | Times Cited: 30
Eline J.M. Bertrums, Jenny L. Smith, Lauren Harmon, et al.
Haematologica (2023) Vol. 108, Iss. 8, pp. 2044-2058
Open Access | Times Cited: 30
Acute Myeloid Leukemia
Xueyan Chen, Brent L. Wood
(2024), pp. 1180-1192
Closed Access | Times Cited: 9
Xueyan Chen, Brent L. Wood
(2024), pp. 1180-1192
Closed Access | Times Cited: 9
CBFA2T3‐GLIS2‐positive acute myeloid leukaemia. A peculiar paediatric entity
Riccardo Masetti, Salvatore Nicola Bertuccio, Andrea Pession, et al.
British Journal of Haematology (2018) Vol. 184, Iss. 3, pp. 337-347
Open Access | Times Cited: 59
Riccardo Masetti, Salvatore Nicola Bertuccio, Andrea Pession, et al.
British Journal of Haematology (2018) Vol. 184, Iss. 3, pp. 337-347
Open Access | Times Cited: 59
Comprehensive Transcriptome Profiling of Cryptic CBFA2T3–GLIS2 Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study
Jenny L. Smith, Rhonda E. Ries, Tiffany Hylkema, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 3, pp. 726-737
Open Access | Times Cited: 59
Jenny L. Smith, Rhonda E. Ries, Tiffany Hylkema, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 3, pp. 726-737
Open Access | Times Cited: 59
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target
Quy Le, Brandon Hadland, Jenny L. Smith, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 22
Open Access | Times Cited: 30
Quy Le, Brandon Hadland, Jenny L. Smith, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 22
Open Access | Times Cited: 30
Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia
Jason E. Farrar, Jenny L. Smith, Megan Othus, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 16, pp. 2949-2962
Open Access | Times Cited: 18
Jason E. Farrar, Jenny L. Smith, Megan Othus, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 16, pp. 2949-2962
Open Access | Times Cited: 18
CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group
Adam J. Lamble, Lisa Eidenschink Brodersen, Todd A. Alonzo, et al.
Journal of Clinical Oncology (2021) Vol. 40, Iss. 3, pp. 252-261
Open Access | Times Cited: 35
Adam J. Lamble, Lisa Eidenschink Brodersen, Todd A. Alonzo, et al.
Journal of Clinical Oncology (2021) Vol. 40, Iss. 3, pp. 252-261
Open Access | Times Cited: 35
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216
Verena Gress, Mathieu Roussy, Luc Boulianne, et al.
Blood Advances (2023) Vol. 8, Iss. 1, pp. 112-129
Open Access | Times Cited: 13
Verena Gress, Mathieu Roussy, Luc Boulianne, et al.
Blood Advances (2023) Vol. 8, Iss. 1, pp. 112-129
Open Access | Times Cited: 13
Novel classification system and high-risk categories of pediatric acute myeloid leukemia
Masayuki Umeda, Yen‐Chun Liu, Seth E. Karol, et al.
Haematologica (2025)
Open Access
Masayuki Umeda, Yen‐Chun Liu, Seth E. Karol, et al.
Haematologica (2025)
Open Access
iPSCs unlock clues to pediatric AML onset
Cornelis Jan Pronk, Charlotta Böiers
Blood (2025) Vol. 145, Iss. 14, pp. 1442-1444
Closed Access
Cornelis Jan Pronk, Charlotta Böiers
Blood (2025) Vol. 145, Iss. 14, pp. 1442-1444
Closed Access
Immunophenotypic clustering in paediatric acute myeloid leukaemia
Hui Liu, Kefei Wu, Wenting Hu, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 6, pp. 2275-2286
Closed Access | Times Cited: 4
Hui Liu, Kefei Wu, Wenting Hu, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 6, pp. 2275-2286
Closed Access | Times Cited: 4
Acute myeloid leukemia with RAM immunophenotype: A report of three patients and comprehensive literature review
Xenia Parisi, Anindita Ghosh, L. Jeffrey Medeiros
eJHaem (2025) Vol. 6, Iss. 1
Open Access
Xenia Parisi, Anindita Ghosh, L. Jeffrey Medeiros
eJHaem (2025) Vol. 6, Iss. 1
Open Access
A Rare Case of Acute Leukemia With CBFA2T3::GLIS2 Fusion Exhibiting a T/Megakaryocyte Mixed Phenotype
Qiang Yao, Jianxia Chen, Meizhu Luo, et al.
Pediatric Blood & Cancer (2025)
Closed Access
Qiang Yao, Jianxia Chen, Meizhu Luo, et al.
Pediatric Blood & Cancer (2025)
Closed Access
Targeting the Rare: A New Therapy for Pediatric Acute Myeloid Leukemia With CBFA2T3-GLIS2 Fusions
Scott N. Furlan
The Hematologist (2025) Vol. 22, Iss. 2
Open Access
Scott N. Furlan
The Hematologist (2025) Vol. 22, Iss. 2
Open Access
Opportunities for immunotherapy in childhood acute myeloid leukemia
Adam J. Lamble, Sarah K. Tasian
Blood Advances (2019) Vol. 3, Iss. 22, pp. 3750-3758
Open Access | Times Cited: 31
Adam J. Lamble, Sarah K. Tasian
Blood Advances (2019) Vol. 3, Iss. 22, pp. 3750-3758
Open Access | Times Cited: 31
Treatment of acute myeloid leukemia in children: A practical perspective
Grace Egan, Yogi Chopra, Stéphanie Mourad, et al.
Pediatric Blood & Cancer (2021) Vol. 68, Iss. 7
Closed Access | Times Cited: 26
Grace Egan, Yogi Chopra, Stéphanie Mourad, et al.
Pediatric Blood & Cancer (2021) Vol. 68, Iss. 7
Closed Access | Times Cited: 26
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group
Karen M. Chisholm, Jenny L. Smith, Amy Heerema‐McKenney, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 5
Closed Access | Times Cited: 10
Karen M. Chisholm, Jenny L. Smith, Amy Heerema‐McKenney, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 5
Closed Access | Times Cited: 10
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms
Todd M. Cooper, Todd A. Alonzo, Sarah K. Tasian, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. S6
Open Access | Times Cited: 9
Todd M. Cooper, Todd A. Alonzo, Sarah K. Tasian, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. S6
Open Access | Times Cited: 9
Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia
Tao Yu, Li Wei, Norio Shiba, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 3
Tao Yu, Li Wei, Norio Shiba, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 3
CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children’s Oncology Group
Andrew J. Menssen, Chad A. Hudson, Todd A. Alonzo, et al.
Haematologica (2024) Vol. 109, Iss. 10, pp. 3182-3193
Open Access | Times Cited: 3
Andrew J. Menssen, Chad A. Hudson, Todd A. Alonzo, et al.
Haematologica (2024) Vol. 109, Iss. 10, pp. 3182-3193
Open Access | Times Cited: 3
Acute myeloid leukemia with rare recurring translocations—an overview of the entities included in the international consensus classification
Synne Dragesund Rørvik, Synne Torkildsen, Øystein Bruserud, et al.
Annals of Hematology (2024) Vol. 103, Iss. 4, pp. 1103-1119
Open Access | Times Cited: 3
Synne Dragesund Rørvik, Synne Torkildsen, Øystein Bruserud, et al.
Annals of Hematology (2024) Vol. 103, Iss. 4, pp. 1103-1119
Open Access | Times Cited: 3
Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children’s Oncology Group protocol AAML0531
Andrew P. Voigt, Lisa Eidenschink Brodersen, Todd A. Alonzo, et al.
Haematologica (2017) Vol. 102, Iss. 12, pp. 2058-2068
Open Access | Times Cited: 25
Andrew P. Voigt, Lisa Eidenschink Brodersen, Todd A. Alonzo, et al.
Haematologica (2017) Vol. 102, Iss. 12, pp. 2058-2068
Open Access | Times Cited: 25
Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Laura Pardo, Andrew P. Voigt, Todd A. Alonzo, et al.
Cytometry Part B Clinical Cytometry (2019) Vol. 98, Iss. 1, pp. 52-56
Open Access | Times Cited: 21
Laura Pardo, Andrew P. Voigt, Todd A. Alonzo, et al.
Cytometry Part B Clinical Cytometry (2019) Vol. 98, Iss. 1, pp. 52-56
Open Access | Times Cited: 21
Impact of age on the survival of pediatric leukemia: an analysis of 15083 children in the SEER database
Yaping Wang, Jie Huang, Liucheng Rong, et al.
Oncotarget (2016) Vol. 7, Iss. 50, pp. 83767-83774
Open Access | Times Cited: 20
Yaping Wang, Jie Huang, Liucheng Rong, et al.
Oncotarget (2016) Vol. 7, Iss. 50, pp. 83767-83774
Open Access | Times Cited: 20